Allen & Hanburys Ltd

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Summary of Product Characteristics last updated on the eMC: 13/09/2011
SPC Beconase Aqueous Nasal Spray

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 10 date of revision of the text
Updated on 01/02/2006 and displayed until 13/09/2011
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 11/01/2005 and displayed until 01/02/2006
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change from the BAN of the active substance to the rINN
Updated on 25/09/2002 and displayed until 11/01/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 01/08/2001 and displayed until 25/09/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/03/2000 and displayed until 01/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 06/03/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   beclometasone dipropionate monohydrate